Literature DB >> 16487956

Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse.

Madhuri Wadehra1, Molina Dayal, Monica Mainigi, Teri Ord, Ramaswamy Iyer, Jonathan Braun, Carmen J Williams.   

Abstract

The establishment of pregnancy requires a successful molecular interaction between the trophectoderm cells of the blastocyst stage embryo and the endometrial cells of the uterus. These interactions are complex and require synchronous development and coordinated endocrine, paracrine, and autocrine communication. In this study, we demonstrate that the tetraspan protein epithelial membrane protein-2 (EMP2) is involved in these molecular interactions during implantation. EMP2, which is highly expressed in the uterus, translocates from an intracellular location to the apical surface of the endometrial epithelium during the window of implantation and is expressed in decidualized stromal cells. We developed plasmid constructs that utilized either ribozyme-mediated or short hairpin RNA-mediated mechanisms to target endometrial EMP2 mRNA for destruction. These constructs were transfected into the mouse uterus on day 1 of pregnancy using the technique of in vivo reproductive tract gene transfer. Reduction in EMP2 expression by either method resulted in a significant decrease in the number of implantation sites in the treated uterine horns as compared to control horns. These studies indicate a previously unknown function of tetraspan proteins in implantation and could provide a molecular framework for the development of therapeutic modalities for both contraception and fertility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487956     DOI: 10.1016/j.ydbio.2006.01.015

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  24 in total

1.  Functional consequences of interactions between FAK and epithelial membrane protein 2 (EMP2).

Authors:  Shawn A Morales; Sergey Mareninov; Paige Coulam; Madhuri Wadehra; Lee Goodglick; Jonathan Braun; Lynn K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-03       Impact factor: 4.799

Review 2.  Regulation of FAK Activity by Tetraspan Proteins: Potential Clinical Implications in Cancer.

Authors:  Yu Qin; Shabnam Mohandessi; Lynn Gordon; Madhuri Wadehra
Journal:  Crit Rev Oncog       Date:  2015

Review 3.  Review of the GAS3 Family of Proteins and their Relevance to Cancer.

Authors:  Negin Ashki; Lynn Gordon; Madhuri Wadehra
Journal:  Crit Rev Oncog       Date:  2015

4.  Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.

Authors:  Maoyong Fu; Erin L Maresh; Robert A Soslow; Mohammad Alavi; Vei Mah; Qin Zhou; Alexia Iasonos; Lee Goodglick; Lynn K Gordon; Jonathan Braun; Madhuri Wadehra
Journal:  Clin Cancer Res       Date:  2010-08-01       Impact factor: 12.531

5.  Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.

Authors:  Omar Habeeb; Lee Goodglick; Robert A Soslow; Rajiv G Rao; Lynn K Gordon; Osvaldo Schirripa; Steve Horvath; Jonathan Braun; David B Seligson; Madhuri Wadehra
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

6.  Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency.

Authors:  Carmen J Williams; Alison Chu; Wendy N Jefferson; David Casero; Deepthi Sudhakar; Nevil Khurana; Claire P Hogue; Chinmayi Aryasomayajula; Priya Patel; Peggy Sullivan; Elizabeth Padilla-Banks; Shabnam Mohandessi; Carla Janzen; Madhuri Wadehra
Journal:  J Pathol       Date:  2017-05-03       Impact factor: 7.996

7.  Rewiring integrin-mediated signaling and cellular response with the peripheral myelin protein 22 and epithelial membrane protein 2 components of the tetraspan web.

Authors:  Shawn A Morales; David Telander; Lucia Notterpek; Madhuri Wadehra; Jonathan Braun; Lynn K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-23       Impact factor: 4.799

8.  FAK activation and the role of epithelial membrane protein 2 (EMP2) in collagen gel contraction.

Authors:  Shawn A Morales; Sergey Mareninov; Madhuri Wadehra; Lily Zhang; Lee Goodglick; Jonathan Braun; Lynn K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-09       Impact factor: 4.799

9.  Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines.

Authors:  Kaori Shimazaki; Eric J Lepin; Bo Wei; Agnes K Nagy; Catherine P Coulam; Sergey Mareninov; Maoyong Fu; Anna M Wu; James D Marks; Jonathan Braun; Lynn K Gordon; Madhuri Wadehra
Journal:  Clin Cancer Res       Date:  2008-11-15       Impact factor: 12.531

10.  Blockade of epithelial membrane protein 2 (EMP2) abrogates infection of Chlamydia muridarum murine genital infection model.

Authors:  Kaori Shimazaki; Ann M Chan; Raymond J Moniz; Madhuri Wadehra; Agnes Nagy; Catherine P Coulam; Sergey Mareninov; Eric M Lepin; Anna M Wu; Kathleen A Kelly; Jonathan Braun; Lynn K Gordon
Journal:  FEMS Immunol Med Microbiol       Date:  2009-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.